Sitagliptin Triazole Hydrochloride CAS 762240-92-6 Purity > 99.0% (HPLC) Hoobkas Zoo

Lus piav qhia luv luv:

Lub npe: Sitagliptin Triazole Hydrochloride

CAS: 762240-92-6 Nr

Purity:> 99.0% (HPLC)

Cov tsos mob: Dawb rau Off-White Crystalline Hmoov

Intermediate ntawm Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9) rau kev kho mob hom II mob ntshav qab zib mellitus

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chemical Properties:

Tshuaj npe 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a] pyrazine Hydrochloride
Synonyms Sitagliptin Triazole Hydrochloride;Sitagliptin Intermediate A
CAS Nr 762240-92-6
CAT Number Qauv: RF-PI1193
Tshuag xwm txheej Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula C6H7F3N4 · HCl
Molecular Luj 228.60 Nws
Melting Point 236.0 ~ 246.0 ℃
Solubility Soluble hauv Methanol
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications
Qhov tshwm sim Dawb rau Off-White Crystalline Hmoov
Kev txheeb xyuas los ntawm HPLC Lub sijhawm khaws cia ntawm cov qauv yog concordant nrog cov qauv siv
Kev txheeb xyuas los ntawm IR Ua raws
Poob rau ziab <0.50%
Yam khoom muaj feem
Ib qho Impurity <0.50%
Tag nrho cov impurities <1.00%
Hnyav Hlau <20 ppm
Purity / Analysis Method > 99.0% (HPLC)
Test Standard Enterprise Standard
Kev siv Intermediate ntawm Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9)

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo.

Qhov zoo:

1

FAQ:

Daim ntawv thov:

3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride (CAS: 762240-92-6) yog ib qho nruab nrab ntawm Sitagliptin Phosphate Monohydrate ( CAS: 654671-77-9), uas yog qhov ncauj-bioavailable xaiv DPP4 inhibitor uas tau tshawb pom los ntawm kev ua kom zoo ntawm chav kawm ntawm β-aminoacid-derived DPP4 inhibitors.Nws txo qis DPP4 kev ua haujlwm nyob rau hauv ib qho kev txhawb nqa tom qab ib zaug kev tswj hwm txhua hnub, khaws cov qib ntawm cov kab mob tsis zoo GIP thiab GLP1 tom qab noj mov hauv ob qho tib si mob thiab mob ntev thiab txo cov ntshav qabzib yam tsis muaj qhov nce hauv hypoglycemia.Sitagliptin Phosphate (STG) yog siv los kho DM hom 2 vim nws txhim kho glycemic tswj los ntawm kev nce qib ntawm cov tshuaj hormones nquag incretin, GLP-1 (peptide-1) thiab GIP (glucose-dependent insulinotropic peptide).STG tau pom zoo los ntawm FDA hauv xyoo 2006.

Sau koj cov lus ntawm no thiab xa tuaj rau peb